Show simple item record

Prevention of Opioid Overdose

dc.contributor.authorBabu, Kavita M.
dc.contributor.authorBrent, Jeffrey
dc.contributor.authorJuurlink, David N.
dc.date2022-08-11T08:08:17.000
dc.date.accessioned2022-08-23T15:49:38Z
dc.date.available2022-08-23T15:49:38Z
dc.date.issued2019-06-06
dc.date.submitted2019-06-07
dc.identifier.citation<p>Babu KM, Brent J, Juurlink DN. Prevention of Opioid Overdose. N Engl J Med. 2019 Jun 6;380(23):2246-2255. doi: 10.1056/NEJMra1807054. <a href="https://doi.org/10.1056/NEJMra1807054" target="_blank" title="Link to article on publisher's site">Link to article on publisher's site</a></p>
dc.identifier.issn1533-4406
dc.identifier.doi10.1056/NEJMra1807054
dc.identifier.pmid31167053
dc.identifier.urihttp://hdl.handle.net/20.500.14038/28482
dc.description.abstractThis review explains harm-reduction strategies for three groups of patients: those who have not received previous opioid therapy, those receiving long-term opioid therapy, and those with an opioid use disorder. It explains both risk assessment and the current approach to the use of medications for opioid use disorder.
dc.language.isoen_US
dc.publisherMassachusetts Medical Society
dc.relation<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/31167053" target="_blank" title="PubMed 31167053">Link to article in PubMed</a></p>
dc.rightsCopyright © 2019 Massachusetts Medical Society. Publisher PDF posted after 6 months as allowed by the publisher's author rights policy at https://www.nejm.org/author-center/permissions.
dc.subjectopioid use disorder
dc.subjectopioids
dc.subjectopioid overdose
dc.subjectprevention
dc.subjectprescriber strategies
dc.subjectopioid therapy
dc.subjectCommunity Health and Preventive Medicine
dc.subjectEmergency Medicine
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectSubstance Abuse and Addiction
dc.titlePrevention of Opioid Overdose
dc.typeJournal Article
dc.source.journaltitleThe New England journal of medicine
dc.source.volume380
dc.source.issue23
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1177&amp;context=emed_pp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/emed_pp/172
dc.legacy.embargo2019-12-06T00:00:00-08:00
dc.identifier.contextkey14688385
refterms.dateFOA2022-08-23T15:49:38Z
html.description.abstract<p>This review explains harm-reduction strategies for three groups of patients: those who have not received previous opioid therapy, those receiving long-term opioid therapy, and those with an opioid use disorder. It explains both risk assessment and the current approach to the use of medications for opioid use disorder.</p>
dc.identifier.submissionpathemed_pp/172
dc.contributor.departmentDivision of Medical Toxicology, Department of Emergency Medicine
dc.source.pages2246-2255


Files in this item

Thumbnail
Name:
nejmra1807054.pdf
Size:
156.3Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record